Disease Info Card

Microcytic Hypochromic Anemia (disorder)

Information about Microcytic Hypochromic Anemia (disorder): characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Microcytic Hypochromic Anemia (disorder)

Most recent studies have shown that Microcytic Hypochromic Anemia (disorder) shares some biological mechanisms with alpha-thalassemia, anemia, anemia-hemolytic, anemia-of-chronic-disease, beta-thalassemia, celiac-disease, deficiency-anaemia, hemoglobinopathies, hemorrhage, hyperplasia, hypochromic-anemia, iron-deficiency, iron-deficiency-anemia, iron-overload, microcytic-anemia, neoplasms, pain, sideroblastic-anemia, thalassemia, thrombocytosis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Microcytic Hypochromic Anemia (disorder), and have been seen in publications frequently: Cell Division, Cell Proliferation, Chemotaxis, Coagulation, Development Of Secondary Sexual Characteristics, Excretion, Flight, Immune Response, Intestinal Absorption, Lactation, Localization, Operant Conditioning, Oxidative Phosphorylation, Parasitism, Pathogenesis, Phagocytosis, Swimming, Symport, Transport, Virulence

Quite a number of genes have been found to play important roles in Microcytic Hypochromic Anemia (disorder), such as ALB, ATP6V0A2, CP, CRP, DMRT1, EPO, FECH, GPHA2, HAMP, HBA1, HBB, PMCH, SGCA, SLC11A2, TF, TMPRSS6. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.